| 000 | 01874 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516101500.0 | ||
| 264 | 0 | _c20130110 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1432-2277 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.2012.01518.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirai, Toshihito | |
| 245 | 0 | 0 |
_aSignificance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cSep 2012 |
||
| 300 |
_a925-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aABO Blood-Group System |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens _xchemistry |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 |
_aHLA Antigens _xchemistry |
| 650 | 0 | 4 |
_aHistocompatibility Testing _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKohei, Naoki | |
| 700 | 1 | _aOmoto, Kazuya | |
| 700 | 1 | _aIshida, Hideki | |
| 700 | 1 | _aTanabe, Kazunari | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 25 _gno. 9 _gp. 925-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.2012.01518.x _zAvailable from publisher's website |
| 999 |
_c21920469 _d21920469 |
||